Submission Details
| 510(k) Number | K200363 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 14, 2020 |
| Decision Date | March 11, 2020 |
| Days to Decision | 26 days |
| Submission Type | Special |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
K200363 is an FDA 510(k) clearance for the Quidel Triage? TOX Drug Screen, 94600, a Enzyme Immunoassay, Amphetamine (Class II — Special Controls, product code DKZ), submitted by Quidel Cardiovascular, Inc. (San Deigo, US). The FDA issued a Cleared decision on March 11, 2020, 26 days after receiving the submission on February 14, 2020. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3100.
| 510(k) Number | K200363 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 14, 2020 |
| Decision Date | March 11, 2020 |
| Days to Decision | 26 days |
| Submission Type | Special |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
| Product Code | DKZ — Enzyme Immunoassay, Amphetamine |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3100 |